• Published 20 Mar 2023

CatSci To Attend CPI Innovation in Oligonucleotide Manufacture Symposium 2023

  • Events

CatSci Ltd are pleased to announce that we will be attending the CPI Innovation in Oligonucleotide Manufacture symposium, taking place in Glasgow on Wednesday 26th April 2023. This event is hosted by CPI’s Medicines Manufacturing Innovation Centre and will bring together key stakeholders from across the sector to discuss the challenges, opportunities, and future of oligonucleotides.

Attending the symposium will be:

CatSci recently announced that we have opened our brand-new, state-of-the-art oligonucleotides laboratory, which was officially opened by the Lord-Lieutenant of South Glamorgan last month. Oligonucleotides have the potential to treat previously untreatable illnesses; we are committed to leveraging our 40+ years of collective experience in oligonucleotide R&D and manufacturing to accelerate the delivery of life-changing medicines.  

Nigel, Aled, and Ali are looking forward to networking with the industry. IF you would like to arrange a meeting with them, get in touch here.  

Resources & Insights

  • 5 Feb 2026
2nd Advances in Translational Drug Development 2026
  • Events
  • 4 Feb 2026
  • Loïc Roux
Make as Insight, Not Execution – Why “Make” Is the Most Misunderstood Step in DMTA
  • Design-Make-Test
  • DMTA
  • Thought Leaders
  • 22 Jan 2026
  • Loïc Roux
Designing Therapeutic Oligonucleotides – A Practical Framework from Biology to Sequence Selection
  • Design-Make-Test
  • DMTA
  • Oligonucleotides
  • Thought Leaders
  • 15 Jan 2026
  • Jordan Fletcher
Peptide Design in Contemporary DMTA Cycles: How DMTA Drives Translational Refinement
  • Design Make Test Analyse
  • DMTA
  • Peptides
  • Thought Leaders